Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:A000250) announced a private placement of series 3 non-guaranteed private convertible bond for gross proceeds of KRW 30,000,000,000 on February 24, 2021. The transaction will include participation from new investors Korea Investment & Securities Co., Ltd., Investment Arm for KRW 5,000,000,000, S.W.S New Technology Association for KRW 22,000,000,000, NH Investment & Securities Co., Ltd., Investment Arm for KRW 2,000,000,000, and KB Securities Co., Ltd., Investment Arm for KRW 1,000,000,000. The bonds will be issued at par. The bonds will not carry any coupon and yield to maturity. The bond would mature on February 26, 2024. The convertible bonds will be 100% convertible into 482,599 common shares at a fixed conversion price of KRW 62,163 per share from February 26, 2022 to January 26, 2024. The securities will have hold period of one year, post the closing. The subscription date and payment date is February 26, 2021. The transaction has been approved by the board of directors of the company.